Overview
Inbiosens provides medical communication software and devices. They are intended to support patient care.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2020, 161 days late).
- 202510/07/2026
- 202414/07/2025
- 202321/06/2024
- 202228/04/2023
- 202114/07/2022
- 202025/03/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Medical communication software
- Medical communication devices
- Patient care software
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board acting independently is authorised to make declarations of will on behalf of the company and to represent the company; if the management board is multi-member, declarations of will on behalf of the company are made and the company is represented by two members of the management board acting jointly, or by a member of the management board together with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Krzysztof Grabowskiage 38 | 37 | $999.46 | 13.0282% |
Tomasz Jadczykage 40 | 37 | $999.46 | 13.0282% |
Konrad Kwiatkowskiage 35 | 37 | $999.46 | 13.0282% |
Tadeusz Uhlage 70 | 99 | $2,674.23 | 34.8592% |
Wojciech Wojakowskiage 56 | 37 | $999.46 | 13.0282% |
Marcin Wołowskiage 43 | 37 | $999.46 | 13.0282% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-12-08.
04 1240 4533 1111 0010 7675 8563
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 4, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $286$286 | Prezes Urzędu Patentowego Rzeczypospolitej Polskiej |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Terapia Plussp. z o.o. | $40,180.80 | terapia-plus.pl | ||
| Smart Labssp. z o.o. | $32,047.41 | smart-labs.pl | ||
| Oncoprojectsp. z o.o. | $3,958.31 | oncoproject.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-11-22 | Share capital change (18,700.00 PLN → 28,400.00 PLN) | |
| 2024-02-26 | Share capital change (12,500.00 PLN → 18,700.00 PLN) | |
| 2023-05-29 | Share capital change (11,000.00 PLN → 12,500.00 PLN) | |
| 2021-09-17 | Address change (Ul. Samuela Bogumiła Lindego 14, 30-148, Kraków → Ul. Zielony Most 6/15, 31-351, Kraków) | |
| 2021-09-17 | Share capital change (10,000.00 PLN → 11,000.00 PLN) |
FAQ
Last updated: 2026-07-16